APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Finasteride Tablet

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oral Finasteride Tablet Market Analysis and Forecast 2026-2032

30 December 2025215 pages

Choose your research edition.

Industry ResearchOral Finasteride Tablet Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Finasteride Tablet Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Oral Finasteride Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Finasteride Tablet Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Finasteride Tablet Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Oral Finasteride Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Finasteride Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oral Finasteride Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oral Finasteride Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oral Finasteride Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oral Finasteride Tablet include Zhejiang Xianju Pharmaceutical Co., Ltd, Tianfang Pharmaceutical Co., Ltd, Shanghai Xinya Pharmaceutical Minhang Co., Ltd, Shanghai Hyundai Pharmaceutical Co., Ltd, Sandoz, Renhetang Pharmaceutical Company Limited, Nanjing Shenghe Pharmaceutical Co., Ltd, Nanjing Sea Whale Pharmaceutical Co., Ltd and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Finasteride Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oral Finasteride Tablet, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Finasteride Tablet, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Finasteride Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Finasteride Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Finasteride Tablet sales, projected growth trends, production technology, application and end-user industry.

Oral Finasteride Tablet Segment by Company

Zhejiang Xianju Pharmaceutical Co., Ltd

Tianfang Pharmaceutical Co., Ltd

Shanghai Xinya Pharmaceutical Minhang Co., Ltd

Shanghai Hyundai Pharmaceutical Co., Ltd

Sandoz

Renhetang Pharmaceutical Company Limited

Nanjing Shenghe Pharmaceutical Co., Ltd

Nanjing Sea Whale Pharmaceutical Co., Ltd

Merck

Runenberg Pharmaceuticals Ltd

CR SECCO Pharmaceutical Co., Ltd

Hunan Zhengqing Pharmaceutical Group Co., Ltd

Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd

Hunan Baicao Pharmaceutical Co., Ltd

Hangzhou Kangenbei Pharmaceutical Co., Ltd

Guangdong Yishu Pharmaceutical Co., Ltd

RelonChem

Dr. Reddy

Cipla

Actavis

Accord Pharmaceuticals

Oral Finasteride Tablet Segment by Type

1mg

5mg

Oral Finasteride Tablet Segment by Application

Urology

Dermatology

Oral Finasteride Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Finasteride Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Finasteride Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Finasteride Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oral Finasteride Tablet in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oral Finasteride Tablet manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Finasteride Tablet sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Finasteride Tablet Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 1mg Major Manufacturers Table 3. 5mg Major Manufacturers Table 4. Global Oral Finasteride Tablet Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Urology Major Manufacturers Table 6. Dermatology Major Manufacturers Table 7. Oral Finasteride Tablet Industry Trends Table 8. Oral Finasteride Tablet Industry Drivers Table 9. Oral Finasteride Tablet Industry Opportunities and Challenges Table 10. Oral Finasteride Tablet Industry Restraints Table 11. Global Oral Finasteride Tablet Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Oral Finasteride Tablet Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Oral Finasteride Tablet Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Oral Finasteride Tablet Revenue Market Share by Region (2021-2026) Table 15. Global Oral Finasteride Tablet Revenue Market Share by Region (2027-2032) Table 16. Global Oral Finasteride Tablet Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Oral Finasteride Tablet Sales by Region (2021-2026) & (K Units) Table 18. Global Oral Finasteride Tablet Sales by Region (2027-2032) & (K Units) Table 19. Global Oral Finasteride Tablet Sales Market Share by Region (2021-2026) Table 20. Global Oral Finasteride Tablet Sales Market Share by Region (2027-2032) Table 21. Global Oral Finasteride Tablet Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Oral Finasteride Tablet Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Oral Finasteride Tablet Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Oral Finasteride Tablet Sales Market Share by Manufacturers (2021-2026) Table 25. Global Oral Finasteride Tablet Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Oral Finasteride Tablet Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Oral Finasteride Tablet Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Oral Finasteride Tablet Manufacturers, Product Type & Application Table 29. Global Oral Finasteride Tablet Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Oral Finasteride Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Oral Finasteride Tablet Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Oral Finasteride Tablet Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Oral Finasteride Tablet Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Oral Finasteride Tablet Revenue Market Share by Type (2021-2026) Table 36. Global Oral Finasteride Tablet Revenue Market Share by Type (2027-2032) Table 37. Global Oral Finasteride Tablet Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 39. Global Oral Finasteride Tablet Sales by Type (2027-2032) & (K Units) Table 40. Global Oral Finasteride Tablet Sales Market Share by Type (2021-2026) Table 41. Global Oral Finasteride Tablet Sales Market Share by Type (2027-2032) Table 42. Global Oral Finasteride Tablet Price by Type (2021-2026) & (US$/Unit) Table 43. Global Oral Finasteride Tablet Price by Type (2027-2032) & (US$/Unit) Table 44. Global Oral Finasteride Tablet Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Oral Finasteride Tablet Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Oral Finasteride Tablet Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Oral Finasteride Tablet Revenue Market Share by Application (2021-2026) Table 48. Global Oral Finasteride Tablet Revenue Market Share by Application (2027-2032) Table 49. Global Oral Finasteride Tablet Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 51. Global Oral Finasteride Tablet Sales by Application (2027-2032) & (K Units) Table 52. Global Oral Finasteride Tablet Sales Market Share by Application (2021-2026) Table 53. Global Oral Finasteride Tablet Sales Market Share by Application (2027-2032) Table 54. Global Oral Finasteride Tablet Price by Application (2021-2026) & (US$/Unit) Table 55. Global Oral Finasteride Tablet Price by Application (2027-2032) & (US$/Unit) Table 56. Zhejiang Xianju Pharmaceutical Co., Ltd Company Information Table 57. Zhejiang Xianju Pharmaceutical Co., Ltd Business Overview Table 58. Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 60. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Development Table 61. Tianfang Pharmaceutical Co., Ltd Company Information Table 62. Tianfang Pharmaceutical Co., Ltd Business Overview Table 63. Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 65. Tianfang Pharmaceutical Co., Ltd Recent Development Table 66. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information Table 67. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Business Overview Table 68. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Product Portfolio Table 70. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Development Table 71. Shanghai Hyundai Pharmaceutical Co., Ltd Company Information Table 72. Shanghai Hyundai Pharmaceutical Co., Ltd Business Overview Table 73. Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 75. Shanghai Hyundai Pharmaceutical Co., Ltd Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sandoz Oral Finasteride Tablet Product Portfolio Table 80. Sandoz Recent Development Table 81. Renhetang Pharmaceutical Company Limited Company Information Table 82. Renhetang Pharmaceutical Company Limited Business Overview Table 83. Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Product Portfolio Table 85. Renhetang Pharmaceutical Company Limited Recent Development Table 86. Nanjing Shenghe Pharmaceutical Co., Ltd Company Information Table 87. Nanjing Shenghe Pharmaceutical Co., Ltd Business Overview Table 88. Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 90. Nanjing Shenghe Pharmaceutical Co., Ltd Recent Development Table 91. Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information Table 92. Nanjing Sea Whale Pharmaceutical Co., Ltd Business Overview Table 93. Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 95. Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Development Table 96. Merck Company Information Table 97. Merck Business Overview Table 98. Merck Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Merck Oral Finasteride Tablet Product Portfolio Table 100. Merck Recent Development Table 101. Runenberg Pharmaceuticals Ltd Company Information Table 102. Runenberg Pharmaceuticals Ltd Business Overview Table 103. Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Product Portfolio Table 105. Runenberg Pharmaceuticals Ltd Recent Development Table 106. CR SECCO Pharmaceutical Co., Ltd Company Information Table 107. CR SECCO Pharmaceutical Co., Ltd Business Overview Table 108. CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 110. CR SECCO Pharmaceutical Co., Ltd Recent Development Table 111. Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information Table 112. Hunan Zhengqing Pharmaceutical Group Co., Ltd Business Overview Table 113. Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Product Portfolio Table 115. Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Development Table 116. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information Table 117. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Business Overview Table 118. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 120. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Development Table 121. Hunan Baicao Pharmaceutical Co., Ltd Company Information Table 122. Hunan Baicao Pharmaceutical Co., Ltd Business Overview Table 123. Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 125. Hunan Baicao Pharmaceutical Co., Ltd Recent Development Table 126. Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information Table 127. Hangzhou Kangenbei Pharmaceutical Co., Ltd Business Overview Table 128. Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 130. Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Development Table 131. Guangdong Yishu Pharmaceutical Co., Ltd Company Information Table 132. Guangdong Yishu Pharmaceutical Co., Ltd Business Overview Table 133. Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 135. Guangdong Yishu Pharmaceutical Co., Ltd Recent Development Table 136. RelonChem Company Information Table 137. RelonChem Business Overview Table 138. RelonChem Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. RelonChem Oral Finasteride Tablet Product Portfolio Table 140. RelonChem Recent Development Table 141. Dr. Reddy Company Information Table 142. Dr. Reddy Business Overview Table 143. Dr. Reddy Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Dr. Reddy Oral Finasteride Tablet Product Portfolio Table 145. Dr. Reddy Recent Development Table 146. Cipla Company Information Table 147. Cipla Business Overview Table 148. Cipla Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Cipla Oral Finasteride Tablet Product Portfolio Table 150. Cipla Recent Development Table 151. Actavis Company Information Table 152. Actavis Business Overview Table 153. Actavis Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Actavis Oral Finasteride Tablet Product Portfolio Table 155. Actavis Recent Development Table 156. Accord Pharmaceuticals Company Information Table 157. Accord Pharmaceuticals Business Overview Table 158. Accord Pharmaceuticals Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Accord Pharmaceuticals Oral Finasteride Tablet Product Portfolio Table 160. Accord Pharmaceuticals Recent Development Table 161. North America Oral Finasteride Tablet Revenue by Type (2021-2026) & (US$ Million) Table 162. North America Oral Finasteride Tablet Revenue by Type (2027-2032) & (US$ Million) Table 163. North America Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 164. North America Oral Finasteride Tablet Sales by Type (2027-2032) & (K Units) Table 165. North America Oral Finasteride Tablet Sales Price by Type (2021-2026) & (US$/Unit) Table 166. North America Oral Finasteride Tablet Sales Price by Type (2027-2032) & (US$/Unit) Table 167. North America Oral Finasteride Tablet Revenue by Application (2021-2026) & (US$ Million) Table 168. North America Oral Finasteride Tablet Revenue by Application (2027-2032) & (US$ Million) Table 169. North America Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 170. North America Oral Finasteride Tablet Sales by Application (2027-2032) & (K Units) Table 171. North America Oral Finasteride Tablet Sales Price by Application (2021-2026) & (US$/Unit) Table 172. North America Oral Finasteride Tablet Sales Price by Application (2027-2032) & (US$/Unit) Table 173. North America Oral Finasteride Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. North America Oral Finasteride Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. North America Oral Finasteride Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. North America Oral Finasteride Tablet Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. North America Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 178. North America Oral Finasteride Tablet Sales by Country (2027-2032) & (K Units) Table 179. North America Oral Finasteride Tablet Sales Price by Country (2021-2026) & (US$/Unit) Table 180. North America Oral Finasteride Tablet Sales Price by Country (2027-2032) & (US$/Unit) Table 181. United States Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 182. Canada Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 183. Europe Oral Finasteride Tablet Revenue by Type (2021-2026) & (US$ Million) Table 184. Europe Oral Finasteride Tablet Revenue by Type (2027-2032) & (US$ Million) Table 185. Europe Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 186. Europe Oral Finasteride Tablet Sales by Type (2027-2032) & (K Units) Table 187. Europe Oral Finasteride Tablet Sales Price by Type (2021-2026) & (US$/Unit) Table 188. Europe Oral Finasteride Tablet Sales Price by Type (2027-2032) & (US$/Unit) Table 189. Europe Oral Finasteride Tablet Revenue by Application (2021-2026) & (US$ Million) Table 190. Europe Oral Finasteride Tablet Revenue by Application (2027-2032) & (US$ Million) Table 191. Europe Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 192. Europe Oral Finasteride Tablet Sales by Application (2027-2032) & (K Units) Table 193. Europe Oral Finasteride Tablet Sales Price by Application (2021-2026) & (US$/Unit) Table 194. Europe Oral Finasteride Tablet Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Europe Oral Finasteride Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Europe Oral Finasteride Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Europe Oral Finasteride Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Europe Oral Finasteride Tablet Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. Europe Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 200. Europe Oral Finasteride Tablet Sales by Country (2027-2032) & (K Units) Table 201. Europe Oral Finasteride Tablet Sales Price by Country (2021-2026) & (US$/Unit) Table 202. Europe Oral Finasteride Tablet Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Germany Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 204. France Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 205. U.K. Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 206. Italy Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 207. Netherlands Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 208. China Oral Finasteride Tablet Revenue by Type (2021-2026) & (US$ Million) Table 209. China Oral Finasteride Tablet Revenue by Type (2027-2032) & (US$ Million) Table 210. China Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 211. China Oral Finasteride Tablet Sales by Type (2027-2032) & (K Units) Table 212. China Oral Finasteride Tablet Sales Price by Type (2021-2026) & (US$/Unit) Table 213. China Oral Finasteride Tablet Sales Price by Type (2027-2032) & (US$/Unit) Table 214. China Oral Finasteride Tablet Revenue by Application (2021-2026) & (US$ Million) Table 215. China Oral Finasteride Tablet Revenue by Application (2027-2032) & (US$ Million) Table 216. China Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 217. China Oral Finasteride Tablet Sales by Application (2027-2032) & (K Units) Table 218. China Oral Finasteride Tablet Sales Price by Application (2021-2026) & (US$/Unit) Table 219. China Oral Finasteride Tablet Sales Price by Application (2027-2032) & (US$/Unit) Table 220. Asia Oral Finasteride Tablet Revenue by Type (2021-2026) & (US$ Million) Table 221. Asia Oral Finasteride Tablet Revenue by Type (2027-2032) & (US$ Million) Table 222. Asia Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 223. Asia Oral Finasteride Tablet Sales by Type (2027-2032) & (K Units) Table 224. Asia Oral Finasteride Tablet Sales Price by Type (2021-2026) & (US$/Unit) Table 225. Asia Oral Finasteride Tablet Sales Price by Type (2027-2032) & (US$/Unit) Table 226. Asia Oral Finasteride Tablet Revenue by Application (2021-2026) & (US$ Million) Table 227. Asia Oral Finasteride Tablet Revenue by Application (2027-2032) & (US$ Million) Table 228. Asia Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 229. Asia Oral Finasteride Tablet Sales by Application (2027-2032) & (K Units) Table 230. Asia Oral Finasteride Tablet Sales Price by Application (2021-2026) & (US$/Unit) Table 231. Asia Oral Finasteride Tablet Sales Price by Application (2027-2032) & (US$/Unit) Table 232. Asia Oral Finasteride Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 233. Asia Oral Finasteride Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 234. Asia Oral Finasteride Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 235. Asia Oral Finasteride Tablet Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 236. Asia Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 237. Asia Oral Finasteride Tablet Sales by Country (2027-2032) & (K Units) Table 238. Asia Oral Finasteride Tablet Sales Price by Country (2021-2026) & (US$/Unit) Table 239. Asia Oral Finasteride Tablet Sales Price by Country (2027-2032) & (US$/Unit) Table 240. Japan Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 241. South Korea Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 242. India Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 243. Australia Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 244. China Taiwan Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 245. Southeast Asia Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 246. SAMEA Oral Finasteride Tablet Revenue by Type (2021-2026) & (US$ Million) Table 247. SAMEA Oral Finasteride Tablet Revenue by Type (2027-2032) & (US$ Million) Table 248. SAMEA Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 249. SAMEA Oral Finasteride Tablet Sales by Type (2027-2032) & (K Units) Table 250. SAMEA Oral Finasteride Tablet Sales Price by Type (2021-2026) & (US$/Unit) Table 251. SAMEA Oral Finasteride Tablet Sales Price by Type (2027-2032) & (US$/Unit) Table 252. SAMEA Oral Finasteride Tablet Revenue by Application (2021-2026) & (US$ Million) Table 253. SAMEA Oral Finasteride Tablet Revenue by Application (2027-2032) & (US$ Million) Table 254. SAMEA Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 255. SAMEA Oral Finasteride Tablet Sales by Application (2027-2032) & (K Units) Table 256. SAMEA Oral Finasteride Tablet Sales Price by Application (2021-2026) & (US$/Unit) Table 257. SAMEA Oral Finasteride Tablet Sales Price by Application (2027-2032) & (US$/Unit) Table 258. SAMEA Oral Finasteride Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 259. SAMEA Oral Finasteride Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 260. SAMEA Oral Finasteride Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 261. SAMEA Oral Finasteride Tablet Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 262. SAMEA Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 263. SAMEA Oral Finasteride Tablet Sales by Country (2027-2032) & (K Units) Table 264. SAMEA Oral Finasteride Tablet Sales Price by Country (2021-2026) & (US$/Unit) Table 265. SAMEA Oral Finasteride Tablet Sales Price by Country (2027-2032) & (US$/Unit) Table 266. Brazil Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 267. Argentina Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 268. Chile Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 269. Colombia Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 270. Peru Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 271. Saudi Arabia Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 272. Israel Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 273. UAE Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 274. Turkey Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 275. Iran Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 276. Egypt Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Table 277. Key Raw Materials Table 278. Raw Materials Key Suppliers Table 279. Oral Finasteride Tablet Distributors List Table 280. Oral Finasteride Tablet Customers List Table 281. Research Programs/Design for This Report Table 282. Authors List of This Report Table 283. Secondary Sources Table 284. Primary Sources List of Figures Figure 1. Oral Finasteride Tablet Image Figure 2. Global Oral Finasteride Tablet Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Finasteride Tablet Market Size Share 2021 VS 2025 VS 2032 Figure 4. 1mg Image Figure 5. 5mg Image Figure 6. Global Oral Finasteride Tablet Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Oral Finasteride Tablet Market Size Share 2021 VS 2025 VS 2032 Figure 8. Urology Image Figure 9. Dermatology Image Figure 10. Global Oral Finasteride Tablet Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Figure 12. Global Oral Finasteride Tablet Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Oral Finasteride Tablet Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Oral Finasteride Tablet Revenue Market Share by Region (2021-2032) Figure 15. Global Oral Finasteride Tablet Sales (2021-2032) & (K Units) Figure 16. Global Oral Finasteride Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Oral Finasteride Tablet Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Oral Finasteride Tablet Sales YoY (2021-2032) & (K Units) Figure 19. Europe Oral Finasteride Tablet Sales YoY (2021-2032) & (K Units) Figure 20. China Oral Finasteride Tablet Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Oral Finasteride Tablet Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Oral Finasteride Tablet Sales YoY (2021-2032) & (K Units) Figure 23. Global Oral Finasteride Tablet Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Oral Finasteride Tablet Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Oral Finasteride Tablet Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Oral Finasteride Tablet Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Oral Finasteride Tablet Revenue Market Share by Type (2021-2032) Figure 29. Global Oral Finasteride Tablet Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Oral Finasteride Tablet Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Oral Finasteride Tablet Sales Market Share by Type (2021-2032) Figure 32. Global Oral Finasteride Tablet Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Oral Finasteride Tablet Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Oral Finasteride Tablet Revenue Market Share by Application (2021-2032) Figure 35. Global Oral Finasteride Tablet Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Oral Finasteride Tablet Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Oral Finasteride Tablet Sales Market Share by Application (2021-2032) Figure 38. North America Oral Finasteride Tablet Revenue Share by Type (2021-2032) Figure 39. North America Oral Finasteride Tablet Sales Share by Type (2021-2032) Figure 40. North America Oral Finasteride Tablet Revenue Share by Application (2021-2032) Figure 41. North America Oral Finasteride Tablet Sales Share by Application (2021-2032) Figure 42. North America Oral Finasteride Tablet Revenue Share by Country (2021-2032) Figure 43. North America Oral Finasteride Tablet Sales Share by Country (2021-2032) Figure 44. Europe Oral Finasteride Tablet Revenue Share by Type (2021-2032) Figure 45. Europe Oral Finasteride Tablet Sales Share by Type (2021-2032) Figure 46. Europe Oral Finasteride Tablet Revenue Share by Application (2021-2032) Figure 47. Europe Oral Finasteride Tablet Sales Share by Application (2021-2032) Figure 48. Europe Oral Finasteride Tablet Revenue Share by Country (2021-2032) Figure 49. Europe Oral Finasteride Tablet Sales Share by Country (2021-2032) Figure 50. China Oral Finasteride Tablet Revenue Share by Type (2021-2032) Figure 51. China Oral Finasteride Tablet Sales Share by Type (2021-2032) Figure 52. China Oral Finasteride Tablet Revenue Share by Application (2021-2032) Figure 53. China Oral Finasteride Tablet Sales Share by Application (2021-2032) Figure 54. Asia Oral Finasteride Tablet Revenue Share by Type (2021-2032) Figure 55. Asia Oral Finasteride Tablet Sales Share by Type (2021-2032) Figure 56. Asia Oral Finasteride Tablet Revenue Share by Application (2021-2032) Figure 57. Asia Oral Finasteride Tablet Sales Share by Application (2021-2032) Figure 58. Asia Oral Finasteride Tablet Revenue Share by Country (2021-2032) Figure 59. Asia Oral Finasteride Tablet Sales Share by Country (2021-2032) Figure 60. SAMEA Oral Finasteride Tablet Revenue Share by Type (2021-2032) Figure 61. SAMEA Oral Finasteride Tablet Sales Share by Type (2021-2032) Figure 62. SAMEA Oral Finasteride Tablet Revenue Share by Application (2021-2032) Figure 63. SAMEA Oral Finasteride Tablet Sales Share by Application (2021-2032) Figure 64. SAMEA Oral Finasteride Tablet Revenue Share by Country (2021-2032) Figure 65. SAMEA Oral Finasteride Tablet Sales Share by Country (2021-2032) Figure 66. Oral Finasteride Tablet Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Oral Finasteride Tablet Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg
  • 5mg
Applications
  • Urology
  • Dermatology
Companies covered
  • Zhejiang Xianju Pharmaceutical Co., Ltd
  • Tianfang Pharmaceutical Co., Ltd
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd
  • Shanghai Hyundai Pharmaceutical Co., Ltd
  • Sandoz
  • Renhetang Pharmaceutical Company Limited
  • Nanjing Shenghe Pharmaceutical Co., Ltd
  • Nanjing Sea Whale Pharmaceutical Co., Ltd
  • Merck
  • Runenberg Pharmaceuticals Ltd
  • CR SECCO Pharmaceutical Co., Ltd
  • Hunan Zhengqing Pharmaceutical Group Co., Ltd
  • Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
  • Hunan Baicao Pharmaceutical Co., Ltd
  • Hangzhou Kangenbei Pharmaceutical Co., Ltd
  • Guangdong Yishu Pharmaceutical Co., Ltd
  • RelonChem
  • Dr. Reddy
  • Cipla
  • Actavis
  • Accord Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oral Finasteride Tablet Market by Type
  3. 1.2.1 Global Oral Finasteride Tablet Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 1mg
  5. 1.2.3 5mg
  6. 1.3 Oral Finasteride Tablet Market by Application
  7. 1.3.1 Global Oral Finasteride Tablet Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Urology
  9. 1.3.3 Dermatology
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Oral Finasteride Tablet Market Dynamics
  1. 2.1 Oral Finasteride Tablet Industry Trends
  2. 2.2 Oral Finasteride Tablet Industry Drivers
  3. 2.3 Oral Finasteride Tablet Industry Opportunities and Challenges
  4. 2.4 Oral Finasteride Tablet Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oral Finasteride Tablet Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oral Finasteride Tablet Revenue by Region
  3. 3.2.1 Global Oral Finasteride Tablet Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oral Finasteride Tablet Revenue by Region (2021-2026)
  5. 3.2.3 Global Oral Finasteride Tablet Revenue by Region (2027-2032)
  6. 3.2.4 Global Oral Finasteride Tablet Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oral Finasteride Tablet Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oral Finasteride Tablet Sales by Region
  9. 3.4.1 Global Oral Finasteride Tablet Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oral Finasteride Tablet Sales by Region (2021-2026)
  11. 3.4.3 Global Oral Finasteride Tablet Sales by Region (2027-2032)
  12. 3.4.4 Global Oral Finasteride Tablet Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oral Finasteride Tablet Revenue by Manufacturers
  2. 4.1.1 Global Oral Finasteride Tablet Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oral Finasteride Tablet Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oral Finasteride Tablet Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oral Finasteride Tablet Sales by Manufacturers
  6. 4.2.1 Global Oral Finasteride Tablet Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oral Finasteride Tablet Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oral Finasteride Tablet Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oral Finasteride Tablet Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oral Finasteride Tablet Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oral Finasteride Tablet Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oral Finasteride Tablet Manufacturers, Product Type & Application
  13. 4.7 Global Oral Finasteride Tablet Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oral Finasteride Tablet Market CR5 and HHI
  16. 4.8.2 2025 Oral Finasteride Tablet Tier 1, Tier 2, and Tier 3
5 Oral Finasteride Tablet Market by Type
  1. 5.1 Global Oral Finasteride Tablet Revenue by Type
  2. 5.1.1 Global Oral Finasteride Tablet Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oral Finasteride Tablet Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oral Finasteride Tablet Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oral Finasteride Tablet Sales by Type
  6. 5.2.1 Global Oral Finasteride Tablet Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Finasteride Tablet Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Oral Finasteride Tablet Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oral Finasteride Tablet Price by Type
6 Oral Finasteride Tablet Market by Application
  1. 6.1 Global Oral Finasteride Tablet Revenue by Application
  2. 6.1.1 Global Oral Finasteride Tablet Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oral Finasteride Tablet Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oral Finasteride Tablet Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oral Finasteride Tablet Sales by Application
  6. 6.2.1 Global Oral Finasteride Tablet Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oral Finasteride Tablet Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Oral Finasteride Tablet Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oral Finasteride Tablet Price by Application
7 Company Profiles
  1. 7.1 Zhejiang Xianju Pharmaceutical Co., Ltd
  2. 7.1.1 Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
  3. 7.1.2 Zhejiang Xianju Pharmaceutical Co., Ltd Business Overview
  4. 7.1.3 Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  6. 7.1.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments
  7. 7.2 Tianfang Pharmaceutical Co., Ltd
  8. 7.2.1 Tianfang Pharmaceutical Co., Ltd Company Information
  9. 7.2.2 Tianfang Pharmaceutical Co., Ltd Business Overview
  10. 7.2.3 Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  12. 7.2.5 Tianfang Pharmaceutical Co., Ltd Recent Developments
  13. 7.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
  14. 7.3.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information
  15. 7.3.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Business Overview
  16. 7.3.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Product Portfolio
  18. 7.3.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments
  19. 7.4 Shanghai Hyundai Pharmaceutical Co., Ltd
  20. 7.4.1 Shanghai Hyundai Pharmaceutical Co., Ltd Company Information
  21. 7.4.2 Shanghai Hyundai Pharmaceutical Co., Ltd Business Overview
  22. 7.4.3 Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  24. 7.4.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments
  25. 7.5 Sandoz
  26. 7.5.1 Sandoz Company Information
  27. 7.5.2 Sandoz Business Overview
  28. 7.5.3 Sandoz Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sandoz Oral Finasteride Tablet Product Portfolio
  30. 7.5.5 Sandoz Recent Developments
  31. 7.6 Renhetang Pharmaceutical Company Limited
  32. 7.6.1 Renhetang Pharmaceutical Company Limited Company Information
  33. 7.6.2 Renhetang Pharmaceutical Company Limited Business Overview
  34. 7.6.3 Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Product Portfolio
  36. 7.6.5 Renhetang Pharmaceutical Company Limited Recent Developments
  37. 7.7 Nanjing Shenghe Pharmaceutical Co., Ltd
  38. 7.7.1 Nanjing Shenghe Pharmaceutical Co., Ltd Company Information
  39. 7.7.2 Nanjing Shenghe Pharmaceutical Co., Ltd Business Overview
  40. 7.7.3 Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  42. 7.7.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments
  43. 7.8 Nanjing Sea Whale Pharmaceutical Co., Ltd
  44. 7.8.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information
  45. 7.8.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Business Overview
  46. 7.8.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  48. 7.8.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments
  49. 7.9 Merck
  50. 7.9.1 Merck Company Information
  51. 7.9.2 Merck Business Overview
  52. 7.9.3 Merck Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Merck Oral Finasteride Tablet Product Portfolio
  54. 7.9.5 Merck Recent Developments
  55. 7.10 Runenberg Pharmaceuticals Ltd
  56. 7.10.1 Runenberg Pharmaceuticals Ltd Company Information
  57. 7.10.2 Runenberg Pharmaceuticals Ltd Business Overview
  58. 7.10.3 Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Product Portfolio
  60. 7.10.5 Runenberg Pharmaceuticals Ltd Recent Developments
  61. 7.11 CR SECCO Pharmaceutical Co., Ltd
  62. 7.11.1 CR SECCO Pharmaceutical Co., Ltd Company Information
  63. 7.11.2 CR SECCO Pharmaceutical Co., Ltd Business Overview
  64. 7.11.3 CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  66. 7.11.5 CR SECCO Pharmaceutical Co., Ltd Recent Developments
  67. 7.12 Hunan Zhengqing Pharmaceutical Group Co., Ltd
  68. 7.12.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information
  69. 7.12.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Business Overview
  70. 7.12.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Product Portfolio
  72. 7.12.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments
  73. 7.13 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
  74. 7.13.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information
  75. 7.13.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Business Overview
  76. 7.13.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  78. 7.13.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments
  79. 7.14 Hunan Baicao Pharmaceutical Co., Ltd
  80. 7.14.1 Hunan Baicao Pharmaceutical Co., Ltd Company Information
  81. 7.14.2 Hunan Baicao Pharmaceutical Co., Ltd Business Overview
  82. 7.14.3 Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  84. 7.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Developments
  85. 7.15 Hangzhou Kangenbei Pharmaceutical Co., Ltd
  86. 7.15.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information
  87. 7.15.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Business Overview
  88. 7.15.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  90. 7.15.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments
  91. 7.16 Guangdong Yishu Pharmaceutical Co., Ltd
  92. 7.16.1 Guangdong Yishu Pharmaceutical Co., Ltd Company Information
  93. 7.16.2 Guangdong Yishu Pharmaceutical Co., Ltd Business Overview
  94. 7.16.3 Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  96. 7.16.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments
  97. 7.17 RelonChem
  98. 7.17.1 RelonChem Company Information
  99. 7.17.2 RelonChem Business Overview
  100. 7.17.3 RelonChem Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 RelonChem Oral Finasteride Tablet Product Portfolio
  102. 7.17.5 RelonChem Recent Developments
  103. 7.18 Dr. Reddy
  104. 7.18.1 Dr. Reddy Company Information
  105. 7.18.2 Dr. Reddy Business Overview
  106. 7.18.3 Dr. Reddy Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Dr. Reddy Oral Finasteride Tablet Product Portfolio
  108. 7.18.5 Dr. Reddy Recent Developments
  109. 7.19 Cipla
  110. 7.19.1 Cipla Company Information
  111. 7.19.2 Cipla Business Overview
  112. 7.19.3 Cipla Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Cipla Oral Finasteride Tablet Product Portfolio
  114. 7.19.5 Cipla Recent Developments
  115. 7.20 Actavis
  116. 7.20.1 Actavis Company Information
  117. 7.20.2 Actavis Business Overview
  118. 7.20.3 Actavis Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Actavis Oral Finasteride Tablet Product Portfolio
  120. 7.20.5 Actavis Recent Developments
  121. 7.21 Accord Pharmaceuticals
  122. 7.21.1 Accord Pharmaceuticals Company Information
  123. 7.21.2 Accord Pharmaceuticals Business Overview
  124. 7.21.3 Accord Pharmaceuticals Oral Finasteride Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Accord Pharmaceuticals Oral Finasteride Tablet Product Portfolio
  126. 7.21.5 Accord Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Oral Finasteride Tablet Market Size by Type
  2. 8.1.1 North America Oral Finasteride Tablet Revenue by Type (2021-2032)
  3. 8.1.2 North America Oral Finasteride Tablet Sales by Type (2021-2032)
  4. 8.1.3 North America Oral Finasteride Tablet Price by Type (2021-2032)
  5. 8.2 North America Oral Finasteride Tablet Market Size by Application
  6. 8.2.1 North America Oral Finasteride Tablet Revenue by Application (2021-2032)
  7. 8.2.2 North America Oral Finasteride Tablet Sales by Application (2021-2032)
  8. 8.2.3 North America Oral Finasteride Tablet Price by Application (2021-2032)
  9. 8.3 North America Oral Finasteride Tablet Market Size by Country
  10. 8.3.1 North America Oral Finasteride Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oral Finasteride Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oral Finasteride Tablet Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Oral Finasteride Tablet Market Size by Type
  2. 9.1.1 Europe Oral Finasteride Tablet Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oral Finasteride Tablet Sales by Type (2021-2032)
  4. 9.1.3 Europe Oral Finasteride Tablet Price by Type (2021-2032)
  5. 9.2 Europe Oral Finasteride Tablet Market Size by Application
  6. 9.2.1 Europe Oral Finasteride Tablet Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oral Finasteride Tablet Sales by Application (2021-2032)
  8. 9.2.3 Europe Oral Finasteride Tablet Price by Application (2021-2032)
  9. 9.3 Europe Oral Finasteride Tablet Market Size by Country
  10. 9.3.1 Europe Oral Finasteride Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oral Finasteride Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oral Finasteride Tablet Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Oral Finasteride Tablet Market Size by Type
  2. 10.1.1 China Oral Finasteride Tablet Revenue by Type (2021-2032)
  3. 10.1.2 China Oral Finasteride Tablet Sales by Type (2021-2032)
  4. 10.1.3 China Oral Finasteride Tablet Price by Type (2021-2032)
  5. 10.2 China Oral Finasteride Tablet Market Size by Application
  6. 10.2.1 China Oral Finasteride Tablet Revenue by Application (2021-2032)
  7. 10.2.2 China Oral Finasteride Tablet Sales by Application (2021-2032)
  8. 10.2.3 China Oral Finasteride Tablet Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oral Finasteride Tablet Market Size by Type
  2. 11.1.1 Asia Oral Finasteride Tablet Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oral Finasteride Tablet Sales by Type (2021-2032)
  4. 11.1.3 Asia Oral Finasteride Tablet Price by Type (2021-2032)
  5. 11.2 Asia Oral Finasteride Tablet Market Size by Application
  6. 11.2.1 Asia Oral Finasteride Tablet Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oral Finasteride Tablet Sales by Application (2021-2032)
  8. 11.2.3 Asia Oral Finasteride Tablet Price by Application (2021-2032)
  9. 11.3 Asia Oral Finasteride Tablet Market Size by Country
  10. 11.3.1 Asia Oral Finasteride Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oral Finasteride Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oral Finasteride Tablet Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oral Finasteride Tablet Market Size by Type
  2. 12.1.1 SAMEA Oral Finasteride Tablet Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oral Finasteride Tablet Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oral Finasteride Tablet Price by Type (2021-2032)
  5. 12.2 SAMEA Oral Finasteride Tablet Market Size by Application
  6. 12.2.1 SAMEA Oral Finasteride Tablet Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oral Finasteride Tablet Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oral Finasteride Tablet Price by Application (2021-2032)
  9. 12.3 SAMEA Oral Finasteride Tablet Market Size by Country
  10. 12.3.1 SAMEA Oral Finasteride Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oral Finasteride Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oral Finasteride Tablet Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oral Finasteride Tablet Value Chain Analysis
  2. 13.1.1 Oral Finasteride Tablet Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oral Finasteride Tablet Production Mode & Process
  6. 13.2 Oral Finasteride Tablet Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oral Finasteride Tablet Distributors
  9. 13.2.3 Oral Finasteride Tablet Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst